Do I need an in-person exam for Lithium in California?

If you’re living with bipolar disorder, accessing consistent treatment can feel like navigating a maze—especially if you’re juggling work, family, or transportation challenges. The good news? Telehealth has opened new doors for bipolar disorder treatment, allowing many people to consult with mental health professionals and receive prescriptions from the comfort of home.

But is it legal? Will your insurance cover it? And most importantly—is it safe?

This guide breaks down everything you need to know about getting bipolar medication through telehealth in 2025, including federal regulations, state-by-state differences, and what to expect from a virtual psychiatric appointment.

Understanding Bipolar Disorder and Treatment Options

Bipolar disorder is a chronic mental health condition characterized by extreme mood swings, including manic or hypomanic episodes (elevated mood, increased energy) and depressive episodes (low mood, loss of interest). According to the National Institute of Mental Health, approximately 4.4% of U.S. adults experience bipolar disorder at some point in their lives.

Effective treatment typically combines medication with therapy. The most commonly prescribed medications for bipolar disorder include:

• Lithium (lithium carbonate) – A mood stabilizer that’s been the gold standard for decades
• Lamotrigine (Lamictal) – An anticonvulsant that helps prevent depressive episodes
• Quetiapine (Seroquel) – An atypical antipsychotic used for both manic and depressive phases

The key detail for telehealth access? None of these medications are controlled substances under federal law. This distinction matters enormously when it comes to prescribing regulations.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Law: The Good News for Telehealth Patients

What Makes Bipolar Medications Different

Unlike ADHD stimulants (like Adderall) or anti-anxiety medications (like Xanax), the most common bipolar medications—Lithium, Lamotrigine, and Quetiapine—are not classified as controlled substances by the Drug Enforcement Administration (DEA).

This means they fall outside the scope of the Ryan Haight Act, the federal law that typically requires an in-person medical evaluation before prescribing controlled substances via telemedicine.

Bottom line: Federal law does not prohibit telehealth prescribing of these mood stabilizers. A licensed psychiatrist, psychiatric nurse practitioner, or other qualified provider can evaluate you via video call and electronically send a prescription to your pharmacy—no in-person visit required by federal regulation.

Current DEA Telehealth Flexibilities

While bipolar medications aren’t affected by controlled substance rules, it’s worth noting the broader telehealth landscape. The DEA has extended temporary flexibilities for prescribing controlled substances via telehealth through December 31, 2026. This extension ensures continued access to mental health care while permanent rules are being finalized.

For patients seeking treatment for conditions like ADHD or anxiety alongside bipolar disorder, this flexibility matters. However, for standard bipolar mood stabilizers, these temporary rules don’t impose additional barriers—telehealth prescribing has always been federally permissible.

State-by-State Considerations: Know Your Local Rules

While federal law sets the baseline, state regulations add another layer to telehealth prescribing. The good news? All 50 states permit telehealth for mental health services, including medication management for bipolar disorder. However, some states have specific requirements.

States With Special Requirements

New Hampshire now requires that patients receiving ongoing telemedicine treatment have at least one evaluation per year (which can be conducted via telehealth). This annual check-in ensures continuity of care and medication safety.

Texas previously restricted certain telehealth prescribing but has carved out clear allowances for mental health treatment, explicitly permitting psychiatric medications to be prescribed virtually.

New York adopted new rules in 2025 for controlled substances (requiring in-person visits with some exceptions), but these regulations do not apply to non-controlled bipolar medications. You can still receive Lithium or Lamotrigine prescriptions via telehealth in New York without an in-person visit.

California is transitioning to broader telehealth flexibility, with proposed legislation (AB 1503) that would clarify standards for asynchronous screening and virtual evaluations—making access even easier.

No State Prohibits Telehealth for Bipolar Medications

Across the 10 most populous states we reviewed (California, Texas, New York, Florida, Delaware, New Hampshire, Pennsylvania, Illinois, Georgia, and Alabama), zero states require an initial in-person visit specifically for prescribing Lithium, Lamotrigine, or Quetiapine. A standard video evaluation meets legal requirements in all these jurisdictions.

Who Can Prescribe Your Bipolar Medication via Telehealth?

Psychiatrists and Primary Care Physicians

Board-certified psychiatrists and licensed physicians (MDs and DOs) can prescribe bipolar medications via telehealth in all states, provided they hold an active license in the state where you’re located at the time of the visit.

Nurse Practitioners: Expanding Access

Psychiatric Nurse Practitioners (PMHNPs) play an increasingly important role in mental health care. As of 2025, over 30 states grant nurse practitioners full independent practice authority, meaning they can diagnose, treat, and prescribe medications without physician oversight.

In states with independent practice authority (like New York, Arizona, and Delaware), a psychiatric NP can manage your entire bipolar treatment plan through telehealth—from initial assessment to ongoing medication management.

Other states require collaborative agreements with physicians (Texas, Florida, Pennsylvania), but this doesn’t prevent NPs from prescribing non-controlled bipolar medications. The collaboration typically happens behind the scenes, and you’ll still receive seamless care through your telehealth platform.

At Klarity Health, our network includes both psychiatrists and psychiatric nurse practitioners licensed across multiple states, ensuring you can connect with an experienced provider who’s authorized to treat you in your location.

What to Expect: The Telehealth Bipolar Medication Process

Initial Assessment

A legitimate telehealth psychiatry visit isn’t a quick five-minute chat. Expect a comprehensive evaluation that typically lasts 30-60 minutes for a first appointment. Your provider will:

• Take a detailed psychiatric history, including past mood episodes
• Review any previous diagnoses and treatments
• Assess current symptoms using standardized criteria (DSM-5)
• Discuss medical history, including other conditions and medications
• Evaluate safety, including suicide risk assessment
• Rule out other causes of mood symptoms (thyroid issues, substance use, etc.)

Diagnostic Criteria and Documentation

Your provider must document that you meet diagnostic criteria for bipolar disorder and that the prescribed medication is clinically appropriate. This documentation serves both medical and legal purposes, ensuring the telehealth encounter meets the same standard of care as an in-person visit.

Many providers will ask you to complete screening questionnaires before your appointment—tools like the Mood Disorder Questionnaire (MDQ) or Patient Health Questionnaire (PHQ-9) help guide the clinical conversation.

Laboratory Monitoring Requirements

If you’re prescribed Lithium, your provider will order baseline lab tests before starting treatment or shortly after. These typically include:

• Kidney function tests (creatinine, BUN)
• Thyroid function (TSH)
• Complete blood count
• Serum lithium level (once you start the medication)

You’ll receive an electronic lab order and can visit any local lab or hospital to complete these tests. Results are sent directly to your provider, who monitors them remotely. Ongoing lithium therapy requires periodic blood level checks (usually every 3-6 months once stable) to ensure safety and effectiveness.

Lamotrigine and Quetiapine don’t require the same intensive lab monitoring, though your provider may recommend baseline metabolic screening, especially for Quetiapine, which can affect blood sugar and cholesterol.

Electronic Prescribing

Once your provider determines medication is appropriate, they’ll send an electronic prescription (e-prescription) directly to your preferred pharmacy. Most states now mandate e-prescribing for all medications, making the process seamless and reducing errors.

You can typically pick up your medication the same day or next day, depending on pharmacy stock. For non-controlled medications like Lithium and Lamotrigine, there are no special restrictions—your pharmacist will process it like any other prescription.

Refills and Ongoing Care

Telehealth providers typically issue 30-day supplies initially, with refills once your dose is stabilized and the medication is well-tolerated. Once you’re stable, many providers will authorize 90-day supplies for convenience.

Ongoing follow-up is essential. Expect check-ins every 1-3 months, especially in the first six months of treatment. These can often be conducted via telehealth as well. Your provider will monitor:

• Symptom improvement and side effects
• Medication adherence
• Lab results (for Lithium)
• Need for dose adjustments

At Klarity Health, we emphasize continuity of care—you’ll see the same provider for follow-ups when possible, ensuring they understand your treatment history and can make informed adjustments.

Safety, Legitimacy, and Red Flags

How to Choose a Reputable Telehealth Provider

Not all online psychiatry services are created equal. Here’s what to look for:

✓ Licensed professionals: Verify that providers are psychiatrists, psychiatric NPs, or physician assistants licensed in your state.

✓ Comprehensive evaluation: Reputable services require detailed intake questionnaires and substantial video visits—not just a brief chat.

✓ No prescription guarantees: Ethical providers never promise a specific medication before evaluating you. Treatment decisions should be based on your individual needs.

✓ Follow-up requirements: Good providers build long-term relationships and require regular check-ins, especially for medications requiring monitoring.

✓ Transparent pricing: Whether you’re using insurance or paying out-of-pocket, costs should be clearly stated upfront.

Red Flags to Avoid

🚩 ‘Guaranteed prescriptions’ – Any service promising medication before assessing you is operating unethically and potentially illegally.

🚩 No video requirement – Federal and state standards generally require live video interaction for psychiatric evaluations (not just phone calls or messaging).

🚩 Skipping monitoring – Prescribing Lithium without discussing lab work is a major safety concern.

🚩 No emergency protocols – Legitimate providers should ask about your support system and local emergency resources, and have a plan if you’re in crisis.

🚩 Unlicensed providers – Always verify your provider’s credentials through your state medical board or nursing board.

Recent Enforcement Actions

The federal government has cracked down on telehealth platforms operating outside the rules. In 2024, the DOJ charged executives of one major ADHD telehealth company with fraud for improperly prescribing controlled substances. Another platform paid $3.6 million to settle allegations of inadequate medical oversight.

These cases involved controlled substances and questionable prescribing practices—not the standard telehealth treatment of bipolar disorder with mood stabilizers. Still, they underscore the importance of choosing legitimate, well-regulated providers.

Insurance Coverage and Cost Considerations

Insurance and Telehealth Parity

Most health insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to pandemic-era policy changes that have been extended or made permanent in many states.

Medicare and Medicaid both cover telehealth mental health services, including psychiatric medication management. Private insurers—including major plans like Aetna, Cigna, UnitedHealthcare, and Blue Cross Blue Shield—generally offer telehealth coverage as well.

At Klarity Health, we accept many major insurance plans and provide transparent pricing. When you schedule, you’ll see your expected out-of-pocket cost based on your coverage, so there are no surprises.

Cash Pay Options

If you’re uninsured or prefer not to use insurance, cash-pay telehealth is often more affordable than traditional in-person psychiatry. Initial consultations typically range from $150-$300, with follow-ups around $75-$150.

Klarity Health offers competitive cash-pay rates with clear pricing displayed upfront. We believe access to mental health care shouldn’t depend on insurance status, so we’ve designed our services to be affordable for people paying out-of-pocket.

Medication Costs

The medications themselves are generally affordable:

• Lithium (generic): $10-$30/month without insurance
• Lamotrigine (generic): $15-$40/month without insurance
• Quetiapine (generic): $20-$50/month without insurance

Brand-name versions cost significantly more, but generic formulations work just as well for most patients. Many pharmacies offer discount programs (like GoodRx or pharmacy savings clubs) that can reduce costs further if you’re paying cash.

Common Questions About Telehealth Bipolar Treatment

Will I ever need an in-person visit?

For regulatory purposes, no—you don’t need an in-person visit to receive standard bipolar medications via telehealth. However, your provider might recommend in-person care in certain situations:

• Severe manic or psychotic episodes requiring hospitalization
• Active suicidal ideation needing immediate intervention
• Physical symptoms requiring hands-on examination
• Complex medical conditions affecting medication choice

These are clinical decisions, not legal requirements.

Can I get therapy through telehealth too?

Yes! Evidence-based therapy approaches like cognitive-behavioral therapy (CBT) and interpersonal and social rhythm therapy (IPSRT) work well via video. Many people benefit from combining medication management with regular therapy sessions—both can be delivered through telehealth.

Klarity Health connects patients with licensed therapists in addition to prescribers, offering comprehensive care in one platform.

What if I’m traveling or move to another state?

Providers must be licensed in the state where you’re physically located at the time of the telehealth visit. If you’re temporarily traveling, you may need to wait until you return to your home state for appointments, unless your provider is also licensed in the state you’re visiting.

If you permanently move, you’ll need a provider licensed in your new state. Reputable platforms have networks across multiple states to ease these transitions.

How quickly can I get started?

Many telehealth platforms offer appointments within days—sometimes even the same week. At Klarity Health, most patients can schedule an initial evaluation within 48-72 hours, depending on provider availability in your state. In urgent situations, we strive to connect you with care as quickly as possible.

Debunking Common Myths

Myth: ‘Online psychiatrists can’t prescribe ‘real’ medications.’
Reality: Telehealth providers can prescribe the exact same medications as in-person doctors, including mood stabilizers, antidepressants, and antipsychotics.

Myth: ‘Telehealth is only for minor mental health issues.’
Reality: Telehealth is appropriate for many people with bipolar disorder, including those managing ongoing treatment. It’s not suitable for everyone (especially during acute crises), but for stable patients or those in mild-to-moderate episodes, it works very well.

Myth: ‘You’ll just get meds without proper evaluation.’
Reality: Legitimate platforms require comprehensive assessments that often exceed the time spent in typical office visits. Providers must meet the same diagnostic standards and documentation requirements.

Myth: ‘Mood stabilizers are controlled substances like Adderall.’
Reality: Lithium, Lamotrigine, and Quetiapine are not controlled substances. They’re in the same prescribing category as antidepressants—meaning fewer regulatory hoops and broader telehealth access.

The Future of Bipolar Disorder Treatment via Telehealth

Telehealth for mental health care is here to stay. Even as temporary pandemic measures expire, states are increasingly adopting permanent telehealth frameworks that expand access to psychiatric care.

Pending federal legislation (like the Telehealth Modernization Act) aims to create a long-term legal structure for controlled substance prescribing, which would solidify the regulatory landscape. While these changes primarily affect ADHD and anxiety medications, they signal broader acceptance of telemedicine in psychiatry.

For people with bipolar disorder, this means greater access to specialized care, especially for those in rural areas, those with mobility challenges, or those who simply prefer the convenience and privacy of home-based treatment.

Taking the Next Step: Getting Started with Telehealth

If you’re considering telehealth for bipolar disorder treatment, here’s how to begin:

1. Research providers in your state who specialize in mood disorders. Look for platforms with strong reviews, licensed clinicians, and clear treatment protocols.

2. Check your insurance to understand your telehealth benefits and out-of-pocket costs (or explore cash-pay options if needed).

3. Prepare for your first appointment by gathering your medical history, previous psychiatric treatment records, current medications, and any relevant lab results.

4. Be honest and thorough during your evaluation. The more information you share, the better your provider can tailor treatment to your needs.

5. Commit to follow-up care. Medication is just one piece of bipolar treatment—ongoing monitoring, therapy, lifestyle changes, and support systems all play crucial roles in long-term stability.

Why Choose Klarity Health for Bipolar Disorder Treatment

At Klarity Health, we’ve built our platform specifically to address the barriers many people face when seeking mental health care:

✓ Provider availability: Our nationwide network of psychiatrists and psychiatric nurse practitioners means shorter wait times—often just days instead of months.

✓ Transparent pricing: We show you the cost upfront, whether you’re using insurance or paying out-of-pocket. No surprise bills.

✓ Flexible payment options: We accept most major insurance plans and offer affordable cash-pay rates for those without coverage or who prefer not to use insurance.

✓ Comprehensive care: Beyond medication management, we can connect you with licensed therapists and provide ongoing support as you navigate your bipolar disorder journey.

✓ Quality you can trust: Our providers are rigorously vetted, fully licensed in your state, and committed to evidence-based treatment protocols.

Bipolar disorder is a lifelong condition, but with the right treatment and support, you can achieve stability, pursue your goals, and live a fulfilling life. Telehealth removes many traditional barriers to accessing that care—making it easier than ever to take control of your mental health.

Ready to get started? Visit Klarity Health to schedule your initial evaluation and take the first step toward comprehensive, convenient bipolar disorder treatment from the comfort of home.

References

1. U.S. Department of Health and Human Services (HHS). ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026.’ Press Release, January 2, 2026. Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Drug Enforcement Administration (DEA). ‘DEA and HHS Extend Telemedicine Flexibilities Through 2025.’ Announcement, November 15, 2024. Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. Sheppard Mullin Health Law Blog. ‘Telehealth and In-Person Visits: Federal and State Updates.’ Published August 15, 2025. Available at: https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/

4. Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (21 U.S.C. § 829(e)). Analysis via Sheppard Mullin. Available at: https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/

5. Texas Board of Nursing. ‘APRN Frequently Asked Questions – Prescriptive Authority.’ Accessed December 2025. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,this%20flexibility%20has%20been%20prolonged
• https://www.sheppardhealthlaw.com/2017/07/articles/health-information-technology/online-pharmacies/#:~:text=,Internet%20without%20a%20valid%20prescription
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=In%20late%202024%2C%20the%20U,V
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=person%20evaluation%20requirement%20under%20the,provide%20short%20term%20stability%20while
• https://www.ama-assn.org/health-care-advocacy/advocacy-update/jan-24-2025-national-advocacy-update#:~:text=telemedicine%20registrations%20for%20prescribing%20Schedule,Like%20the%20buprenorphine%20rule
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=The%20Fourth%20Temporary%20Extension%2C%20along,flexibilities%20under%20the%20fourth%20temporary
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,long%20as%20the%20issuing%20provider
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=1,a
• https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/#:~:text=5,a%20physician%20must%20generally%20use